Angelman syndrome is a rare neurogenetic disorder affecting approximately 1 in 15,000 live births or 500,000 people globally.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...

Hinge Health leads in digital physiotherapy with strong ROI, sensor-free tech, and major growth potential in public and ...

Shares of Hinge Health jumped 22% above the initial public offering price in the company's New York Stock Exchange debut ...

Daniel is an Independent Director at Henry Schein, Inc., a Chairman at Therapy Brands Holdings LLC and a Chairman at Bettcher Industries, Inc. He is on the Board of Directors at Henry Schein, Inc., ...

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients skip daily maintenance drugs.

Eli Lilly is doubling down on its gene therapy ambitions with a $1.3 billion pact with Rznomics. The goal? Use RNA editing to treat sensorineural hearing loss. Unlike the gene-splicing thrill ride ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new ...

Mindfulness-based therapy can offer significant relief for individuals who are still depressed after receiving treatment, according to a new clinical trial. Researchers hope their findings ...

Michelle Obama has looked to therapy to help her process the new stage of her life. Mental health maintenance is a necessity, and the former First Lady realized she needed therapy as her roles as ...

Shares in more than a dozen gene and cell therapy developers tumbled by double digits Wednesday after a well-known critic of the speedy approval paths their treatments often rely on was named to lead ...